Physician profile
David L Feingold
NPI 1407807316
$1,341.42
in general payments reported to CMS, 2019-2025
16 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $67.19 · 2021: $86.52 · 2022: $235 · 2023: $203 · 2024: $169 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $436.33 | 2019-2025 | Journey II, Anthology, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $181.41 | 2019-2025 | Minibunion, Monovisc |
| Vertex Pharmaceuticals Incorporated | $170.01 | 2024-2025 | |
| Bioventus LLC | $104.87 | 2024-2025 | Supartz Fx Sodium Hyaluronate, Exogen Ultrasound Bone Healing System, Durolane |
| Fidia Pharma USA INC. | $102.25 | 2022-2024 | Hymovis, Triluron, Hyalgan |
| Stryker Corporation | $59.87 | 2025 | Inspace |
| Ferring Pharmaceuticals INC. | $48.79 | 2019 | |
| Horizon Therapeutics Plc | $43.84 | 2021 | |
| Abbott Laboratories | $43.09 | 2025 | Octrode, Proclaim |
| Ethicon US, LLC | $35.99 | 2020 | |
| Globus Medical, INC. | $24.86 | 2023 | Allocate |
| Dynasplint Systems INC. | $23.86 | 2022 | |
| Vericel Corporation | $23.43 | 2019 | |
| Medtronic USA, INC. | $17.39 | 2019 | |
| Orthofix Medical, INC. | $13.44 | 2024 | Physio-Stim |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team_makena_llc | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Feingold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.